Work

[Molecular and genetic aspects of triple negative breast cancer and therapeutic implications].

Year: 2011
Type: article
Abstract: Triple negative breast cancers are defined by the lack of expression of estrogen, progesterone and HER2 receptors. They represent an heterogeneous population with poor prognosis. The treatment of these tumors is a challenge because there is no known specific target. A huge number of studies try to better characterise these tumors at the molecular level with the aim to identify new therapeutic targets. The finding of new specific biomarkers like intracellular and extracellular microRNAs is also an important field of research. This article reviews some recent data in this field and the research on different pathways for the development of new therapies.
Source: PubMed
Language: French
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W164648092
FWCI: 0.194
Cites: 20
Cited by: 3
Related to: 9